Economic Times Top Court in India Rejects Novartis Drug Patent New York Times NEW DELHI — India's Supreme Court rejected a Swiss drug maker's patent application for a major cancer drug Monday in a landmark ruling that allows cheap copies of important medicines to continue being distributed in much of the world. Novartis: India rejects patent plea for cancer drug Glivec BBC News Novartis loses Indian patent fight on cancer drug AFP India Court Rejects Novartis Drug-Patent Plea Wall Street Journal Times of India - The Hindu - Boston.com all 94 news articles »
Read this article:
Top Court in India Rejects Novartis Drug Patent - New York
Brak komentarzy:
Prześlij komentarz